Loading...
Medpace Holdings, Inc.
MEDP•NASDAQ
Healthcare
Medical - Diagnostics & Research
$453.05
$5.56(1.24%)
Medpace Holdings, Inc. (MEDP) Financial Performance & Income Statement Overview
Review Medpace Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
11.84%
↑ 11.84%
Operating Income Growth
32.67%
↑ 32.67%
Net Income Growth
42.99%
↑ 42.99%
Operating Cash Flow Growth
40.48%
↑ 40.48%
Operating Margin
21.40%
↑ 21.40%
Gross Margin
31.62%
↑ 31.62%
Net Profit Margin
18.74%
↑ 18.74%
ROE
67.66%
↑ 67.66%
ROIC
135.95%
↑ 135.95%
Medpace Holdings, Inc. (MEDP) Income Statement & Financial Overview
Review Medpace Holdings, Inc.'s (MEDP) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $558.57M | $536.59M | $533.32M | $528.10M |
| Cost of Revenue | $380.22M | $358.27M | $364.31M | $374.27M |
| Gross Profit | $178.35M | $178.32M | $169.008M | $153.84M |
| Gross Profit Ratio | $0.32 | $0.33 | $0.32 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $57.90M | $45.43M | $49.22M | $41.45M |
| Operating Expenses | $64.83M | $52.94M | $56.73M | $48.69M |
| Total Costs & Expenses | $445.05M | $411.21M | $421.04M | $422.95M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $6.93M | $7.51M | $7.52M | $7.24M |
| EBITDA | $120.45M | $132.88M | $119.79M | $112.39M |
| EBITDA Ratio | $0.22 | $0.25 | $0.22 | $0.21 |
| Operating Income | $113.52M | $125.38M | $112.27M | $105.15M |
| Operating Income Ratio | $0.20 | $0.23 | $0.21 | $0.20 |
| Other Income/Expenses (Net) | $4.65M | $8.50M | $6.50M | $5.33M |
| Income Before Tax | $118.17M | $133.88M | $118.78M | $110.48M |
| Income Before Tax Ratio | $0.21 | $0.25 | $0.22 | $0.21 |
| Income Tax Expense | $3.58M | $16.86M | $22.35M | $22.13M |
| Net Income | $114.59M | $117.02M | $96.43M | $88.35M |
| Net Income Ratio | $0.21 | $0.22 | $0.18 | $0.17 |
| EPS | $3.77 | $3.78 | $3.11 | $2.85 |
| Diluted EPS | $3.67 | $3.67 | $3.01 | $2.75 |
| Weighted Avg Shares Outstanding | $30.39M | $30.95M | $31.05M | $30.99M |
| Weighted Avg Shares Outstanding (Diluted) | $31.20M | $32.01M | $32.09M | $32.09M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan